Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 12, 2008

TcLand Expression, a spin-out of the French research institute INSERM/ITERT that focuses on gene expression biomarkers in immunology, has appointed Alessandra Cervino as vice president of bioinformatics and biostatistics, and Patrick Larcier, as vice president of clinical and regulatory affairs.
Cervino will manage the statistical and bioinformatics teams. Previous to TcLand Expression, she was head of statistical sciences and assistant professor at Scripps Florida, where she conducted a genome-wide study of lupus and developed a workflow to combine genotypic and transcriptomic data to identify novel genes.
She was group leader in statistical genetics at Rosetta/Merck, where she worked to translate genetic research programs into new drug targets and pharmacogenetic programs. She holds a PhD in clinical medicine from the University of Oxford.
Larcier will run clinical and regulatory operations, and will be responsible for the global relationship with regulatory agencies. Before joining the firm, he was vice president of drug development at Neovacs, an antibody-therapy company, and associate director of international regulatory affairs at Biogen.

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.